318 results
S-1/A
EX-3.1
PRPO
Precipio Inc
17 May 00
IPO registration (amended)
12:00am
of the Corporation by the vote of a majority of the entire
Board of Directors. In addition to any requirements of law and any other
provision …
the affirmative
3
vote of the holders of a majority or more of the combined voting power
S-1
EX-3.1
PRPO
Precipio Inc
10 Mar 00
IPO registration
12:00am
, the Board of Directors is expressly authorized to adopt, repeal, alter or
amend the By-laws of the Corporation by the vote of a majority of the entire …
vote of the holders of a majority or more of the combined voting power of the
then outstanding stock of the Corporation entitled to vote generally
8-K
EX-3
PRPO
Precipio Inc
25 May 07
Amendments to Articles of Incorporation or Bylaws
12:00am
only be called (i) by the Chairman of the Board, (ii) by the Board of Directors pursuant to a resolution adopted by a majority of the entire Board … be transacted which might have been transacted at the original meeting. [Section 222.]
Section 5.Quorum and Adjournment. The holders of a majority
S-1
EX-3.2
PRPO
Precipio Inc
10 Mar 00
IPO registration
12:00am
to a resolution adopted by a
majority of the entire Board of Directors or (iii) by the Chief Executive
Officer, if one is appointed, otherwise the President … .]
Section 5. QUORUM AND ADJOURNMENT. The holders of a majority of the
stock issued and outstanding and entitled to vote thereat, present in person
8-K
EX-3.2
mnzdsxs9xcsn8 wz11c
30 Jun 17
Precipio Diagnostics and Transgenomic Complete Merger
12:00am
8-K
EX-3.1
0kre6n
30 Jun 17
Precipio Diagnostics and Transgenomic Complete Merger
12:00am
8-K
EX-10.5
zygsaq1be o6x
30 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
lnd76 8di
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
424B3
ds8cysep8s4eqqyzso
13 Feb 19
Prospectus supplement
5:17pm
8-K
EX-3.2
0kwpwcbz0tf931bbu6ky
29 May 12
Amendments to Articles of Incorporation or Bylaws
12:00am
S-1
EX-10.6
0l7elxxifie o0
10 Mar 00
IPO registration
12:00am
8-K
EX-3.1
hd8jfvy
4 Jan 11
Transgenomic Announces Closing of the Acquisition of Clinical Data’s Diagnostic Business and the Closing of a $6 Million Financing
12:00am
8-K
EX-3.2
e3fbl1 6d0ir76
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
S-1
EX-10.5
7pkkew594vv ge
10 Mar 00
IPO registration
12:00am
DEFA14A
1ofrbtaxwqkw8 as3gzo
19 Oct 16
Additional proxy soliciting materials
12:00am